These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 5553515)
21. [Prognosis of chronic hepatitis. II. Duration of the disease]. Selmair H; Vido I; Wildhirt E Dtsch Med Wochenschr; 1969 Oct; 94(43):2220-2. PubMed ID: 5343413 [No Abstract] [Full Text] [Related]
22. The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the Hepatitis C Anti-viral Long-term Treatment against Cirrhosis Trial. Everson GT; Shiffman ML; Morgan TR; Hoefs JC; Sterling RK; Wagner DA; Kulig CC; Curto TM; Wright EC; Aliment Pharmacol Ther; 2008 May; 27(9):798-809. PubMed ID: 18266997 [TBL] [Abstract][Full Text] [Related]
23. [Therapy of liver cirrhosis]. Paumgartner G Z Gastroenterol Verh; 1983 Apr; 18():63-9. PubMed ID: 6192610 [No Abstract] [Full Text] [Related]
24. [Prognosis of chronic hepatitis. 1. Forms and developmental stages]. Vido I; Selmair H; Wildhirt E; Ortmans H Dtsch Med Wochenschr; 1969 Oct; 94(43):2215-6 passim. PubMed ID: 5343412 [No Abstract] [Full Text] [Related]
25. Histopathology of chronic viral hepatitis: guidelines for a revised classification. Callea F; Baronchelli C; Rodolfi A; Bonetti MF; Brisigotti M Ital J Gastroenterol; 1995 Apr; 27(3):137-40. PubMed ID: 7548923 [TBL] [Abstract][Full Text] [Related]
27. [Problem of definition and classification of chronic hepatitis]. Yamagata S; Wakui K Nihon Rinsho; 1970 Feb; 28(2):218-22. PubMed ID: 5462715 [No Abstract] [Full Text] [Related]
28. [Coinfection in hepatitis]. Häussinger D; Erhardt A; Oette M Z Gastroenterol; 2004 Aug; 42(8):724-30. PubMed ID: 15314724 [No Abstract] [Full Text] [Related]
29. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472 [TBL] [Abstract][Full Text] [Related]
30. [Evolutive possibilities in chronic hepatitis]. Fodor O; Ban A; Barbarino F; Cosma V; Stănescu L Med Interna (Bucur); 1965 Dec; 17(12):1385-95. PubMed ID: 5863214 [No Abstract] [Full Text] [Related]
31. [Primary chronic hepatitis. Anatomoclinical and etiological entities]. Dediu S Med Interna (Bucur); 1968 May; 20(5):541-55. PubMed ID: 5735427 [No Abstract] [Full Text] [Related]
32. The global impact of hepatic fibrosis and end-stage liver disease. Lim YS; Kim WR Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463 [TBL] [Abstract][Full Text] [Related]
33. [Chronic hepatitis. Current problems]. Thomas M; Hecht Y Nouv Presse Med; 1972 Feb; 1(9):573-4. PubMed ID: 5022902 [No Abstract] [Full Text] [Related]
34. [Chronic viral hepatitis: protocol proposal for the management of cirrhosis]. Diaz-Brito V; Cardoso H; Sarmento A Acta Med Port; 2008; 21(2):179-92. PubMed ID: 18625097 [TBL] [Abstract][Full Text] [Related]
35. [Clinical picture and prognosis of chronic hepatitis]. Ichida F; Sasaki H; Inoue K Naika; 1969 Feb; 23(2):212-24. PubMed ID: 5783325 [No Abstract] [Full Text] [Related]
36. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine. Sponseller CA; Bacon BR; Di Bisceglie AM Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057 [TBL] [Abstract][Full Text] [Related]
37. Classification and treatment of chronic active liver disease. Geall MG; Schoenfield LJ; Summerskill WH Gastroenterology; 1968 Dec; 55(6):724-9. PubMed ID: 5727785 [No Abstract] [Full Text] [Related]
38. [On therapy of active chronic hepatitis and its sequelae with azathiorpine (Imurel)]. Ruhland H; Moch P Med Klin; 1969 Jan; 64(3):112-7. PubMed ID: 5764141 [No Abstract] [Full Text] [Related]
39. Classification and treatment of liver disease. Tygstrup N Ann Clin Res; 1982 Jun; 14(3):148-53. PubMed ID: 7137887 [No Abstract] [Full Text] [Related]